Healthcare ETF ASX | Health Sector ETF | BetaShares
  • Request info pack
  • Download factsheet
  • Request a call
  • Request Lonsec research
  • View all funds
  • Download Factsheet

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits of DRUG

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

How to invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX.
  • Fund requires no minimum investment.

KEY FACTS

Pricing Information 6 March 2021

Current Price
Last Trade* -
% Change (prev day) -
Bid (delayed) -
Offer (delayed) -
* Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit* $6.76
* As at 4 March 2021

Profile

Net Assets* ($A) $89,411,585
Units Outstanding* (#) 13,218,623
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 4 March 2021
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN Index
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 8.2
UNITEDHEALTH GROUP INC 6.1
ROCHE HOLDING AG 4.6
ABBOTT LABORATORIES 4.2
NOVARTIS AG 3.9
ABBVIE INC 3.8
PFIZER INC 3.7
THERMO FISHER SCIENTIFIC INC 3.6
MERCK & CO INC 3.5
ELI LILLY AND CO 3.4
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 8.2 Equities Healthcare United States USD 37,835 $7,498,904 $7,498,904
UNH UN UNITEDHEALTH GROUP INC 6.1 Equities Healthcare United States USD 12,955 $5,599,519 $5,599,519
ROG SE ROCHE HOLDING AG 4.6 Equities Healthcare Switzerland CHF 9,983 $4,227,268 $4,227,268
ABT UN ABBOTT LABORATORIES 4.2 Equities Healthcare United States USD 25,473 $3,826,392 $3,826,392
NOVN SE NOVARTIS AG 3.9 Equities Healthcare Switzerland CHF 32,690 $3,561,379 $3,561,379
ABBV UN ABBVIE INC 3.8 Equities Healthcare United States USD 25,374 $3,471,142 $3,471,142
PFE UN PFIZER INC 3.7 Equities Healthcare United States USD 75,892 $3,360,749 $3,360,749
TMO UN THERMO FISHER SCIENTIFIC INC 3.6 Equities Healthcare United States USD 5,696 $3,255,932 $3,255,932
MRK UN MERCK & CO INC 3.5 Equities Healthcare United States USD 34,544 $3,228,073 $3,228,073
LLY UN ELI LILLY AND CO 3.4 Equities Healthcare United States USD 12,099 $3,141,698 $3,141,698
MDT UN MEDTRONIC PLC 3.0 Equities Healthcare United States USD 18,356 $2,739,733 $2,739,733
DHR UN DANAHER CORP 2.9 Equities Healthcare United States USD 9,597 $2,666,358 $2,666,358
BMY UN BRISTOL-MYERS SQUIBB CO 2.7 Equities Healthcare United States USD 32,477 $2,495,384 $2,495,384
NOVOB DC NOVO NORDISK A/S 2.6 Equities Healthcare Denmark DKK 26,050 $2,360,457 $2,360,457
AZN LN ASTRAZENECA PLC 2.3 Equities Healthcare Britain GBP 17,352 $2,140,553 $2,140,553
AMGN UW AMGEN INC 2.3 Equities Healthcare United States USD 7,446 $2,139,508 $2,139,508
SAN FP SANOFI 2.0 Equities Healthcare France EUR 15,380 $1,829,533 $1,829,533
GSK LN GLAXOSMITHKLINE PLC 1.6 Equities Healthcare Britain GBP 67,064 $1,477,013 $1,477,013
SYK UN STRYKER CORP 1.6 Equities Healthcare United States USD 4,699 $1,435,133 $1,435,133
ISRG UW INTUITIVE SURGICAL INC 1.5 Equities Healthcare United States USD 1,537 $1,411,361 $1,411,361
ANTM UN ANTHEM INC 1.5 Equities Healthcare United States USD 3,360 $1,398,688 $1,398,688
CI UN CIGNA CORP 1.5 Equities Healthcare United States USD 4,777 $1,389,122 $1,389,122
ZTS UN ZOETIS INC 1.4 Equities Healthcare United States USD 6,830 $1,273,495 $1,273,495
GILD UW GILEAD SCIENCES INC 1.4 Equities Healthcare United States USD 15,134 $1,239,056 $1,239,056
BDX UN BECTON DICKINSON AND CO 1.3 Equities Healthcare United States USD 3,918 $1,222,022 $1,222,022
BAYN GY BAYER AG 1.2 Equities Healthcare Germany EUR 13,272 $1,055,671 $1,055,671
4502 JT TAKEDA PHARMACEUTICAL CO LTD 1.1 Equities Healthcare Japan JPY 22,700 $1,029,244 $1,029,244
BSX UN BOSTON SCIENTIFIC CORP 1.1 Equities Healthcare United States USD 20,580 $1,010,746 $1,010,746
4568 JT DAIICHI SANKYO CO LTD 1.0 Equities Healthcare Japan JPY 25,700 $934,988 $934,988
PHIA NA KONINKLIJKE PHILIPS NV 1.0 Equities Healthcare Netherlands EUR 13,094 $917,615 $917,615
EW UN EDWARDS LIFESCIENCES CORP 1.0 Equities Healthcare United States USD 8,510 $902,239 $902,239
ILMN UW ILLUMINA INC 1.0 Equities Healthcare United States USD 1,721 $890,494 $890,494
EL FP ESSILORLUXOTTICA SA 1.0 Equities Consumer Discretionary France EUR 4,286 $890,149 $890,149
HUM UN HUMANA INC 0.9 Equities Healthcare United States USD 1,655 $833,243 $833,243
MRNA UW MODERNA INC 0.9 Equities Healthcare United States USD 4,778 $818,502 $818,502
LONN SE LONZA GROUP AG 0.9 Equities Healthcare Switzerland CHF 1,070 $812,115 $812,115
HCA UN HCA HEALTHCARE INC 0.9 Equities Healthcare United States USD 3,550 $810,575 $810,575
VRTX UW VERTEX PHARMACEUTICALS INC 0.9 Equities Healthcare United States USD 2,915 $784,291 $784,291
7741 JT HOYA CORP 0.8 Equities Healthcare Japan JPY 5,400 $768,856 $768,856
IDXX UW IDEXX LABORATORIES INC 0.8 Equities Healthcare United States USD 1,152 $724,717 $724,717
BAX UN BAXTER INTERNATIONAL INC 0.7 Equities Healthcare United States USD 6,901 $682,862 $682,862
REGN UW REGENERON PHARMACEUTICALS INC 0.7 Equities Healthcare United States USD 1,130 $657,516 $657,516
BIIB UW BIOGEN INC 0.7 Equities Healthcare United States USD 1,858 $634,097 $634,097
2269 HK WUXI BIOLOGICS CAYMAN INC 0.7 Equities Healthcare China HKD 41,000 $629,401 $629,401
ALC SE ALCON INC 0.7 Equities Healthcare Switzerland CHF 7,031 $616,706 $616,706
2413 JT M3 INC 0.6 Equities Healthcare Japan JPY 5,900 $575,860 $575,860
ZBH UN ZIMMER BIOMET HOLDINGS INC 0.6 Equities Healthcare United States USD 2,830 $572,559 $572,559
DXCM UW DEXCOM INC 0.6 Equities Healthcare United States USD 1,187 $547,575 $547,575
4503 JT ASTELLAS PHARMA INC 0.6 Equities Healthcare Japan JPY 25,500 $525,489 $525,489
CNC UN CENTENE CORP 0.6 Equities Healthcare United States USD 6,750 $518,202 $518,202
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.6 Equities Healthcare Japan JPY 9,700 $518,114 $518,114
4543 JT TERUMO CORP 0.5 Equities Healthcare Japan JPY 9,500 $460,824 $460,824
SGEN UW SEAGEN INC 0.5 Equities Healthcare United States USD 2,333 $439,382 $439,382
RMD UN RESMED INC 0.5 Equities Healthcare United States USD 1,833 $434,456 $434,456
068270 KP CELLTRION INC 0.4 Equities Healthcare South Korea KRW 1,108 $389,043 $389,043
COLOB DC COLOPLAST A/S 0.4 Equities Healthcare Denmark DKK 1,935 $360,713 $360,713
FRE GY FRESENIUS SE & CO KGAA 0.4 Equities Healthcare Germany EUR 5,849 $324,270 $324,270
FME GY FRESENIUS MEDICAL CARE AG & CO 0.3 Equities Healthcare Germany EUR 3,021 $267,919 $267,919
207940 KP SAMSUNG BIOLOGICS CO LTD 0.2 Equities Healthcare South Korea KRW 238 $203,941 $203,941
DIM FP SARTORIUS STEDIM BIOTECH 0.2 Equities Healthcare France EUR 344 $182,237 $182,237
AUD AUD - AUSTRALIA DOLLAR FX Forwards AUD 91,921,596 $91,921,596
CHF CHF - SWISS FRANC FX Forwards CHF -6,707,751 -$9,344,875
DKK DKK - DANISH KRONE FX Forwards DKK -13,325,746 -$2,777,412
EUR EUR - EURO FX Forwards EUR -3,636,022 -$5,635,496
GBP GBP - BRITISH POUND FX Forwards GBP -2,025,125 -$3,643,294
HKD HKD - HONG KONG DOLLAR FX Forwards HKD -4,195,406 -$700,051
JPY JPY - JAPANESE YEN FX Forwards JPY -422,232,508 -$5,064,683
KRW KRW - KOREAN WON FX Forwards KRW -491,116,115 -$562,615
USD USD - UNITED STATES DOLLAR FX Forwards USD -51,251,271 -$66,361,868
Download CSV
* As at 4 March 2021. Excludes cash

Sector Allocation

Pharmaceuticals
45.0%
* As of 29 January 2021

Country Allocation

United States
70.0%
Switzerland
10.3%
Japan
5.6%
Britain
4.1%
France
3.0%
Denmark
2.8%
Germany
1.8%
Netherlands
1.0%
China
0.8%
South Korea
0.7%
* As of 29 January 2021

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month -2.57% -2.47%
3 months 0.72% 0.93%
6 months 1.62% 1.87%
1 year 14.38% 15.03%
3 year p.a 9.51% 9.76%
5 year p.a - 10.33%
Since inception (p.a) 8.28% 8.60%
Inception date 4-Aug-16 -
* As at 26 February 2021

Chart

Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 0.8%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 29 January 2021. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
4-Jan-21 5-Jan-21 19-Jan-21 $0.0166 1.00%
1-Jul-20 2-Jul-20 16-Jul-20 $0.04292 1.13%
2-Jan-20 3-Jan-20 17-Jan-20 $0.02494 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.70%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
Product Disclosure Statement - Global Sector Series
Download
Annual Report - June 2020
Download
NRWT and Fund Payment Notice information - December 2020 distributions
Download
NRWT and Fund Payment Notice information - June 2020 distributions
Download
Notice of Modifications to Fund Constitution – AMIT Tax Regime
Download
Interim Financial Report 2018
Download
2020 BetaShares Distribution Calendar
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack